Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial

Guardado en:
Autores principales: Mina C. Hosseinipour, Gregory P. Bisson, Sachiko Miyahara, Xin Sun, Agnes Moses, Cynthia Riviere, Fredrick K Kirui, Sharlaa Badal‐Faesen, David Lagat, Mulinda Nyirenda, Kogieleum Naidoo, James Hakim, Peter Mugyenyi, Germán Henostroza, Paul Leger, Javier R. Lama, Lerato Mohapi, Jorge Alave, Vidya Mave, Valdiléa G. Veloso, Sandy Pillay, Nagalingeswaran Kumarasamy, Jing Bao, Evelyn Hogg, Lynne Jones, Andrew Zolopa, Johnstone Kumwenda, Amita Gupta
Formato: Artículo
Lenguaje:inglés
Publicado: 2016
Materias:
Medicine
Tuberculosis
Isoniazid
Internal medicine
Clinical endpoint
Population
Randomized controlled trial
Pediatrics
Environmental health
Pathology
Adult
Ambulatory Care Facilities
Antitubercular Agents therapeutic use
Female
Humans
Isoniazid therapeutic use
Male
Tuberculosis immunology
Tuberculosis prevention & control
HIV Infections drug therapy
HIV Infections immunology
Treatment Outcome
AIDS-Related Opportunistic Infections immunology
AIDS-Related Opportunistic Infections prevention & control
CD4 Lymphocyte Count
Anti-HIV Agents therapeutic use
Kaplan-Meier Estimate
Health Sciences Medicine Infectious Diseases HIV/AIDS drug development and treatment
Health Sciences Medicine Infectious Diseases Tuberculosis Research and Epidemiology
Health Sciences Medicine Infectious Diseases HIV/AIDS Research and Interventions
Acceso en línea:Ver en el sistema de origen
Ver en el sistema de origen
Enlace permanente (DOI o Handle)
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares: Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial

Ejemplares similares